Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN Imprimir: 2151-8017
ISSN En Línea: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.2017020161
pages 237-254

Chlamydia pneumoniae Infection and Inflammatory Diseases

Rebecca A. Porritt
Division of Pediatric Infectious Diseases and Immunology, Burns and Allen Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048
Timothy R. Crother
Division of Pediatric Infectious Diseases and Immunology, Burns and Allen Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048

SINOPSIS

Chlamydia pneumonia, an obligate intracellular bacterial pathogen, has long been investigated as a potential developmental or exacerbating factor in various pathologies. Its unique lifestyle and ability to disseminate throughout the host while persisting in relative safety from the immune response has placed this obligate intracellular pathogen in the crosshairs as a potentially mitigating factor in chronic inflammatory diseases. Many animal model and human correlative studies have been performed to confirm or deny a role for C. pneumonia infection in these disorders. In some cases, antibiotic clinical trials were conducted to prove a link between bacterial infections and atherosclerosis. In this review, we detail the latest information regarding the potential role that C. pneumonia infection may have in chronic inflammatory diseases.


Articles with similar content:

Understanding Lung Immunopathology Caused by the Human Metapneumovirus: Implications for Rational Vaccine Design
Critical Reviews™ in Immunology, Vol.35, 2015, issue 3
Claudia A. Riedel, Christian E. Palavecino, Alexis M. Kalergis, Susan M. Bueno, Pablo F. Cespedes, Margarita K. Lay
Chlamydial Infection of Immune Cells: Altered Function and Implications for Disease
Critical Reviews™ in Immunology, Vol.29, 2009, issue 4
Wilhelmina M. Huston, Peter Timms, Kenneth Beagley, Philip M. Hansbro
Treatment of Chemotherapy Induced Peripheral Neuropathy: The Role of Medicinal Herbs
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 1
Sven Schroeder, Gesa Meyer-Hamme, Thomas Friedemann
Mechanisms of Induction of Tolerance to Organ Allografts
Critical Reviews™ in Immunology, Vol.20, 2000, issue 4
Bruce Hall
IL-21 Is an Immune Activator That also Mediates Suppression via IL-10
Critical Reviews™ in Immunology, Vol.30, 2010, issue 6
Warren J. Leonard, Rosanne Spolski